Year archive

Nykode Therapeutics ASA — 2023 filings

All 103 regulatory filings released by Nykode Therapeutics ASA (NYKD) in 2023, sourced directly from the official regulator.

103 Filings

2023 Period

2023 filings (103)

Filing	Released	Lang
Nykode Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference Regulatory Filings	2023-12-19	English
Nykode Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference Report Publication Announcement	2023-12-19	English
Financial calendar Report Publication Announcement	2023-12-18	English
Nykode Therapeutics Announces Expansion of Oncology Pipeline Aiming to Reduce the Burden of Colorectal Cancer Regulatory Filings	2023-12-14	English
Nykode Therapeutics Announces Expansion of Oncology Pipeline Aiming to Reduce the Burden of Colorectal Cancer Regulatory Filings	2023-12-14	English
Nykode Therapeutics - Share capital increase from exercise of warrants Share Issue/Capital Change	2023-12-07	English
Nykode Therapeutics - Share capital increase from exercise of warrants Share Issue/Capital Change	2023-11-28	English
Nykode Therapeutics – Primary insider transaction Director's Dealing	2023-11-24	English
Nykode Therapeutics – Primary insider transaction Remuneration Information	2023-11-24	English
Nykode Therapeutics - Quarterly report Q3 2023 Interim / Quarterly Report Q3 2023	2023-11-15	English
Nykode Therapeutics - Quarterly report Q3 2023 Report Publication Announcement Q3 2023	2023-11-15	English
Nykode Therapeutics - Share capital increase from exercise of warrants Share Issue/Capital Change	2023-11-10	English
Nykode Therapeutics – invitation to Q3 2023 financial results presentation Report Publication Announcement	2023-11-09	English
Nykode Therapeutics – invitation to Q3 2023 financial results presentation Report Publication Announcement	2023-11-09	English
Nykode Therapeutics to Present at Jefferies Healthcare Conference Report Publication Announcement	2023-11-07	English
Nykode Therapeutics to Present at Jefferies Healthcare Conference Regulatory Filings	2023-11-07	English
Nykode Therapeutics - Mandatory notification of acquisition of shares by primary insider Director's Dealing	2023-10-31	English
Nykode Therapeutics - Mandatory notification of acquisition of shares by primary insider Major Shareholding Notification	2023-10-31	English
Disclosure of shareholding Major Shareholding Notification	2023-10-31	English
Nykode Therapeutics ASA – New Share Capital Registered Share Issue/Capital Change	2023-10-31	English
Nykode Therapeutics ASA – Subsequent Offering Cancelled Share Issue/Capital Change	2023-10-30	English
Nykode Therapeutics - Mandatory notification of acquisition of shares by primary insider Director's Dealing	2023-10-27	English
Nykode Therapeutics - Mandatory notification of acquisition of shares by primary insider Director's Dealing	2023-10-27	English
Nykode Therapeutics - Mandatory notification of trade by closely associated party of a primary Insider Board/Management Information	2023-10-25	English
Nykode Therapeutics - Mandatory notification of trade by closely associated party of a primary Insider Director's Dealing	2023-10-25	English
Nykode Therapeutics - Mandatory notification of trade by closely associated party of a primary Insider Director's Dealing	2023-10-25	English
Nykode Therapeutics - Mandatory notification of trade by closely associated party of a primary Insider Director's Dealing	2023-10-25	English
Disclosure of shareholding Major Shareholding Notification	2023-10-25	English
Disclosure of shareholding Major Shareholding Notification	2023-10-25	English
Nykode Therapeutics ASA – Share Lending by Closely Associated Parties of a Primary Insider Director's Dealing	2023-10-25	English
Nykode Therapeutics ASA – Share Lending by Closely Associated Parties of a Primary Insider Regulatory Filings	2023-10-25	English
Nykode Therapeutics ASA – Key Information Regarding Subsequent Offering Share Issue/Capital Change	2023-10-24	English
Nykode Therapeutics ASA - Private Placement Completed Capital/Financing Update	2023-10-24	English
Nykode Therapeutics ASA - Contemplated Private Placement Capital/Financing Update	2023-10-24	English
Nykode Therapeutics - Update on process with the Norwegian Tax Authorities Legal Proceedings Report	2023-10-23	English
Nykode Therapeutics – presentation from the mRNA Cancer Vaccines Summit 2023 in Boston Report Publication Announcement	2023-10-12	English
Nykode Therapeutics – presentation from the mRNA Cancer Vaccines Summit 2023 in Boston Investor Presentation	2023-10-12	English
Nykode Therapeutics – presentation from the mRNA Cancer Vaccines Summit 2023 in Boston Investor Presentation	2023-10-12	English
Nykode Therapeutics to Present at the mRNA Cancer Vaccines Summit 2023 in Boston Regulatory Filings	2023-10-09	English
Nykode Therapeutics to Present at the mRNA Cancer Vaccines Summit 2023 in Boston Regulatory Filings	2023-10-09	English
Nykode Therapeutics Initiates Phase 1/2a Trial of VB10.16 in First Line HPV16-Positive Head and Neck Cancer Legal Proceedings Report	2023-09-29	English
Nykode Therapeutics Initiates Phase 1/2a Trial of VB10.16 in First Line HPV16-Positive Head and Neck Cancer Regulatory Filings	2023-09-29	English
Nykode Therapeutics - presentation from Capital Markets Day in Oslo Investor Presentation	2023-09-27	English
Nykode Therapeutics - presentation from Capital Markets Day in Oslo Report Publication Announcement	2023-09-27	English
Nykode Therapeutics - presentation from Capital Markets Day in Oslo Report Publication Announcement	2023-09-27	English
Nykode Therapeutics - Invitation to Capital Markets Day in Oslo on September 27, 2023 Report Publication Announcement	2023-09-25	English
Nykode Therapeutics - Invitation to Capital Markets Day in Oslo on September 27, 2023 AGM Information	2023-09-25	English
Nykode Therapeutics - Invitation to Capital Markets Day in Oslo on September 27, 2023 Regulatory Filings	2023-09-25	English
Nykode Therapeutics Announces Advances in Clinical Pipeline and Research Investor Presentation	2023-09-20	English
Nykode Therapeutics Announces Advances in Clinical Pipeline and Research Earnings Release Q2 2023	2023-09-20	English
Nykode Therapeutics Announces Advances in Clinical Pipeline and Research Regulatory Filings	2023-09-20	English
Nykode Therapeutics to Present at H.C. Wainwright 25th Annual Global Investment Conference Report Publication Announcement	2023-09-11	English
Nykode Therapeutics to Present at H.C. Wainwright 25th Annual Global Investment Conference Regulatory Filings	2023-09-11	English
Nykode Therapeutics – Invitation to Capital Markets Day in New York on September 20, 2023 Report Publication Announcement	2023-09-07	English
Nykode Therapeutics – Invitation to Capital Markets Day in New York on September 20, 2023 AGM Information	2023-09-07	English
Nykode Therapeutics – Invitation to Capital Markets Day in New York on September 20, 2023 Regulatory Filings	2023-09-07	English
Nykode Therapeutics Announces FDA Approval of IND for VB-C-04, a Trial of VB10.16 in HPV16-Positive Cervical Cancer Regulatory Filings	2023-09-05	English
Nykode Therapeutics Announces FDA Approval of IND for VB-C-04, a Trial of VB10.16 in HPV16-Positive Cervical Cancer Regulatory Filings	2023-09-05	English
Nykode Therapeutics - Quarterly report Q2 2023 Interim / Quarterly Report Q2 2023	2023-08-23	English
Nykode Therapeutics - Quarterly report Q2 2023 Report Publication Announcement Q2 2023	2023-08-23	English
Nykode Therapeutics to announce financial results for the second quarter 2023 and host webcast presentation on August 23, 2023 Report Publication Announcement	2023-08-17	English
Grant of share options Director's Dealing	2023-07-07	English
Grant of share options Share Issue/Capital Change	2023-07-07	English
Nykode Therapeutics – updated company presentation July 2023 Investor Presentation	2023-07-03	English
Nykode Therapeutics – updated company presentation July 2023 Investor Presentation	2023-07-03	English
Nykode Therapeutics Announces Expansion of Clinical Collaboration with Roche to Evaluate VB10.16 in Combination with anti-PD-L1 in the next trial in Advanced Cervical Cancer Regulatory Filings	2023-06-01	English
Nykode Therapeutics Announces Expansion of Clinical Collaboration with Roche to Evaluate VB10.16 in Combination with anti-PD-L1 in the next trial in Advanced Cervical Cancer Regulatory Filings	2023-06-01	English
Nykode Therapeutics to Present at Jefferies Healthcare Conference Report Publication Announcement	2023-05-30	English
Nykode Therapeutics to Present at Jefferies Healthcare Conference Regulatory Filings	2023-05-30	English
Grant of share options Director's Dealing	2023-05-26	English
Grant of share options Regulatory Filings	2023-05-26	English
Nykode Therapeutics - Quarterly report Q1 2023 Interim / Quarterly Report Q1 2023	2023-05-12	Norwegian
Nykode Therapeutics - Quarterly report Q1 2023 Report Publication Announcement Q1 2023	2023-05-12	English
Nykode Therapeutics ASA - Minutes of Annual General Meeting AGM Information	2023-05-11	English
Nykode Therapeutics ASA - Minutes of Annual General Meeting AGM Information	2023-05-11	English
Disclosure of voting rights at AGM Declaration of Voting Results & Voting Rights Announcements	2023-05-10	English
Financial calendar Report Publication Announcement	2023-05-08	English
Nykode Therapeutics to announce financial results for the first quarter 2023 and host webcast presentation on May 12, 2023 Report Publication Announcement	2023-05-08	English
Nykode Therapeutics to announce financial results for the first quarter 2023 and host webcast presentation on May 12, 2023 Report Publication Announcement	2023-05-08	English
Nykode Therapeutics ASA - Notice of Annual General Meeting AGM Information	2023-04-20	Norwegian
Nykode Therapeutics ASA - Notice of Annual General Meeting AGM Information	2023-04-20	Norwegian
Nykode Therapeutics ASA - Notice of Annual General Meeting AGM Information	2023-04-20	English
Nykode Therapeutics - Annual Report 2022 Annual Report FY 2022	2023-04-19	English
Nykode Therapeutics - Annual Report 2022 Environmental & Social Information	2023-04-19	English
Nykode Therapeutics - Annual Report 2022 Annual Report FY 2022	2023-04-19	English
Nykode Therapeutics - Annual Report 2022 Report Publication Announcement	2023-04-19	English
Nykode Therapeutics announces positive final results from its Phase 2 trial of VB10.16 in combination with PD-L1 inhibitor atezolizumab in advanced cervical cancer Earnings Release Q2 2023	2023-04-18	English
Nykode Therapeutics announces positive final results from its Phase 2 trial of VB10.16 in combination with PD-L1 inhibitor atezolizumab in advanced cervical cancer Investor Presentation	2023-04-18	English
Nykode Therapeutics announces positive final results from its Phase 2 trial of VB10.16 in combination with PD-L1 inhibitor atezolizumab in advanced cervical cancer Regulatory Filings	2023-04-18	English
Nykode Therapeutics - Quarterly report 4Q 2022 Interim / Quarterly Report Q4 2022	2023-02-28	English
Nykode Therapeutics - Quarterly report 4Q 2022 Earnings Release Q4 2022	2023-02-28	English
Nykode Therapeutics to announce financial results for the fourth quarter 2022 and host webcast presentation on February 28, 2023 Report Publication Announcement	2023-02-22	English
Nykode Therapeutics to announce financial results for the fourth quarter 2022 and host webcast presentation on February 28, 2023 Report Publication Announcement	2023-02-22	English
Nykode Therapeutics ASA – Flaggemelding Jan Haudemann-Andersen Director's Dealing	2023-02-13	Norwegian
Nykode Therapeutics Announces Collaboration with The GOG Foundation, Inc. to Conduct the VB-C-04 Trial in Advanced Cervical Cancer Regulatory Filings	2023-02-10	English
Nykode Therapeutics Announces Collaboration with The GOG Foundation, Inc. to Conduct the VB-C-04 Trial in Advanced Cervical Cancer Regulatory Filings	2023-02-10	English
Nykode Therapeutics to Present at SVB Securities Global Biopharma Conference Report Publication Announcement	2023-02-07	English
Nykode Therapeutics to Present at SVB Securities Global Biopharma Conference Regulatory Filings	2023-02-07	English
Registration of new share capital Share Issue/Capital Change	2023-02-01	English
Exercise of warrants and related transactions by primary insiders Director's Dealing	2023-01-25	English
Exercise of warrants and related transactions by primary insiders Director's Dealing	2023-01-25	English
Nykode Therapeutics - Presentation at the 41st Annual J.P. Morgan Healthcare Conference Investor Presentation	2023-01-09	English
Nykode Therapeutics - Presentation at the 41st Annual J.P. Morgan Healthcare Conference Investor Presentation	2023-01-09	English